[Regional catheter thrombolysis for late proximal deep vein thrombosis].

Objective: To compare the efficacy of regional catheter thrombolysis with urokinase and alteplase for late proximal deep vein thrombosis.

Material And Methods: We analyzed safety and effectiveness of treatment of 38 patients with late proximal deep vein thrombosis divided into 2 statistically homogeneous groups by 19 people. In the first group, regional thrombolysis with urokinase was performed with injection of the drug into thrombosed popliteal, femoral and iliac veins.

[Venous stenting in acute period of total and subtotal deep vein thrombosis].

Objective: To study the efficacy and safety of venous stenting and long-term anticoagulation with inhibitors of blood clotting factor XA in the treatment of total and subtotal deep vein thrombosis.

Material And Methods: We analyzed 60 patients with total and subtotal deep vein thrombosis divided into 2 comparable groups by 30 people. Patients of the first group underwent regional catheter thrombolysis and percutaneous mechanical thrombectomy.

[Efficacy of percutaneous mechanical thrombectomy for proximal deep vein thrombosis].

Objective: To study the efficacy and safety of percutaneous mechanical thrombectomy and long-term anticoagulation with rivaroxaban for proximal deep vein thrombosis.

Material And Methods: We analyzed the effectiveness of treatment in 60 patients with proximal deep vein thrombosis divided into 2 homogeneous groups by 30 people. Standard therapy was performed in the first group, therapy with percutaneous mechanical thrombectomy was applied in the second group.

[One-year results of conservative and endovascular treatment of deep venous thrombosis followed by severe acute venous insufficiency].

Objective: To compare the results of conservative and endovascular treatment of deep vein thrombosis followed by acute severe venous insufficiency.

Material And Methods: Two statistically valid groups of patients with deep vein thrombosis and acute severe venous insufficiency were compared. Warfarin was administered in the first group, endovascular methods - in the second group (=30).